Rocket Lab: Defense Contracts and Iridium Deal Create an Asymmetric Long - Trade Plan Inside

Hook & thesis

Rocket Lab is no longer only an upstart rideshare launcher. Two large U.S. defense awards in early August and the announced acquisition of Iridium transform it into a vertically integrated launch-to-satellite operator with real defense revenue tailwinds. That pivot is actionable: I rate RKLB a Strong Buy for a long-term trade targeting the $120 level over the coming 180 trading days, with a disciplined stop to contain downside.

The market is assigning a lot of optionality (and a very high multiple) to RKLB today, but the company's combination of a $2.2B backlog, repeatable launch business and recurring revenue potential from Iridium argues for upside if execution holds. This is not a low-volatility play; it is an asymmetric risk/reward where a handful of successful launches, contract realizations and integration wins could re-rate the stock materially.

What Rocket Lab does and why the market should care

Rocket Lab builds and operates rockets and spacecraft. The business breaks down into two segments:

• Launch Services - dedicated missions and rideshares. Growing cadence and the upcoming Neutron vehicle are meant to push Rocket Lab from small-sat launch boutique toward medium-class repeatable lift.
• Space Systems - spacecraft design, components, manufacturing and on-orbit mission operations. This segment is the bridge to recurring, service-style revenue once satellites are in orbit.

The market cares because Rocket Lab is executing a vertical integration strategy: owning the launch and the spacecraft/service layers widens margins over time and positions the company to sell bundled solutions to governments and commercial customers. The recent wins show this strategy winning work in the defense procurement cycle.

Big numbers that justify the thesis

Those numbers illustrate why the stock trades at a premium: the market is pricing significant future growth and margin expansion into today’s share price. Revenue more than doubled from 2023 to 2025 and backlog at $2.2B provides revenue visibility. Defense contracts are substantial and specific: a $266M award for hypersonic test launches and a separate $397M contract for Flatellites (reported 08/04/2026) give near-term revenue and credibility with defense customers.

Valuation framing

At a market cap around $47B and EV / Sales roughly 67x, Rocket Lab is priced like a high-growth, high-margin software/recurring revenue business rather than a capital-intensive aerospace manufacturer. That premium is justified only if two things happen: (1) sustained revenue growth driven both by launch cadence and satellite services (including Iridium), and (2) a path to profitability and positive free cash flow. Analysts projecting profitability and positive free cash flow in 2027 (mid-2027 cited for the Iridium close) provide the narrative that can close the gap between aspiration and valuation.

Practically, the market is paying for a story: successful Neutron development and launches, predictable government launch demand, and the integration of Iridium's recurring services. If those pieces align, multiples can compress because the denominator (earnings and FCF) grows quickly.

Catalysts to drive the trade

• Defense contract execution - the $266M hypersonic launch package (reported 08/02/2026) and the $397M Flatellite award (reported 08/04/2026) should convert into revenue and positive free cash flow contribution as missions execute.
• Neutron development and first flights - a successful Neutron series of flights would materially increase addressable market and justify higher per-launch pricing and reuse economics.
• Iridium acquisition close and integration - the announced $8B deal, expected to close mid-2027, is the largest strategic lever; successful integration can create recurring satellite-comm revenue and accelerate the path to profitability.
• Backlog realization - the company’s $2.2B backlog provides revenue visibility; steady conversion into launches and satellite builds will validate forward guidance.

Trade plan (actionable)

Entry: $74.80
Stop loss: $62.00
Target: $120.00

Horizon: long term (180 trading days). I expect the trade to play out over several quarters as the Iridium transaction progresses, defense contracts begin to generate revenue, and Neutron development milestones are announced and met. The 180 trading day horizon gives time for revenue recognition, guidance updates, and multiple re-rating events if execution is on plan.

Rationale: Entering at $74.80 buys into current defense contract visibility and backlog conversion at a price well below the 52-week high. The $62 stop limits downside to roughly 17% while preserving upside if one or more catalysts materialize. The $120 target is a balanced objective that prices in a significant multiple compression only if the company shows a clear, near-term path to profit and FCF—something analysts are already forecasting for 2027 contingent on the Iridium close.

Technical & market context

Short interest is moderate relative to float but short volume has been meaningful on many recent days, indicating active two-way trading. Momentum indicators are neutral-to-positive: the 10-day SMA is $67.27, 20-day SMA $70.38 and 50-day SMA $93.25; RSI sits around 48 and MACD shows bullish momentum. In practice, this means the trade should be monitored around news events and volume spikes—defense contract timelines and Neutron updates will likely be the most market-moving items.

Risks and counterarguments

• Dilution and financing risk: The $8B Iridium acquisition will likely require debt and/or equity financing. That raises the risk of dilution or higher interest costs that could push out profitability.
• Execution risk on Neutron: Rocket Lab’s future hinges on Neutron performing to expectations. Development setbacks, delays or failed flights would be materially negative.
• Cash burn and negative FCF: Recent free cash flow was negative ~$316M. Continued cash burn without improvement increases the chance of equity raises or debt that squeezes margins.
• Concentration on government defense spending: While defense contracts are high-quality when signed, they can be subject to programmatic changes, schedule shifts or budget approvals that delay revenue.
• Valuation sensitivity: At EV / Sales near 67x, any miss on growth or profitability could trigger a sharp multiple contraction—even if underlying revenue grows.

Counterargument: One could argue the stock already prices in a best-case path and that near-term setbacks (integration costs, launch issues or slower Iridium revenue recognition) will cause a substantial downshift. The valuation is aggressive and dependent on multiple moving parts converging—if those do not align, downside could be severe.

What would change my mind

I would downgrade the trade if any of the following happen: a) clear delays or failures in Neutron flight testing; b) material deterioration in cash flow (significantly larger negative FCF than the recent ~$316M) without credible financing plans; c) the Iridium deal falls apart or is re-priced in a way that increases dilution materially; or d) defense contract awards are delayed or canceled. Conversely, I would add to the position if Rocket Lab posts sequential quarters showing positive operating income and accelerating free cash flow or if the Iridium integration progresses on time with incremental recurring revenue visible.

Conclusion

Rocket Lab is a high-conviction, high-risk trade. The company is moving up the value chain from launch provider to integrated satellite and services operator, driven by large defense contracts, a substantial backlog and the transformational Iridium acquisition. The market’s premium multiple reflects those expectations. For traders and investors comfortable with aerospace execution risk and potential near-term volatility, I rate RKLB a Strong Buy into $74.80 with a $62 stop and a $120 target over 180 trading days. Keep position sizing disciplined and watch Neutron milestones, defense contract execution and the Iridium close as the primary binary outcomes for the trade.

Key dates and headlines to watch

• Defense contract milestones and launch schedules tied to the $266M hypersonic work - reported 08/02/2026.
• Flatellite program contract updates and timeline - reported 08/04/2026.
• Progress on Iridium close and integration steps (expected mid-2027).